Allergy and Airway |

Endobronchial Mass Due to MAC Infection Despite Macrolide Prophylaxis FREE TO VIEW

Sebastian Circo, MD; Thomas Dillard, MD; WIlliam Davis, MD
Author and Funding Information

Georgia Regents University, Augusta, GA

Chest. 2013;144(4_MeetingAbstracts):32A. doi:10.1378/chest.1704773
Text Size: A A A
Published online


SESSION TITLE: Bronchology Cases I

SESSION TYPE: Affiliate Case Report Slide

PRESENTED ON: Sunday, October 27, 2013 at 01:15 PM - 02:45 PM

INTRODUCTION: Mycobacterium Avium Complex (MAC) is an ubiquitous bacteria known to cause lung disease in immunosuppressed individuals. Pulmonary involvement can range from asymptomatic colonization to diffuse parenchymal disease and cavitary lesions. We present the case of an AIDS patient recently started on antiretroviral therapy that developed a large polypoid endobronchial mass caused by MAC infection.

CASE PRESENTATION: A 38 year old African American female presented to the hospital with one month history of progressive shortness of breath, non productive cough and recent onset hemoptysis. She has a four year history of HIV disease and previous intermittent exposure to antiretrovirals, with poor compliance. Her symptoms developed three weeks after starting therapy with raltegravir, efavirenz, emtricitabine, tenofovir as well as MAC prophylaxis with azythromycin. Her CD4 count at presentation was 31 cells/mcL compared to 2 cells/mcL six weeks earlier. Her initial chest radiograph showed patchy multilobular densities in the right lung. Chest CT showed a large right paratracheal mass extending into the lower trachea and right mainstem with infiltrates in the right upper and middle lobes. Bronchoscopy revealed a right sided tracheal polypoid mass extending to the main carina. Forceps biopsy was performed. The pathology report showed granulation-like tissue with abundant macrophages that contained numerous acid-fast bacilli and no evidence of malignancy. The large number of bacilli within macrophages suggested infection by MAC, which was confirmed by growth on bronchoalveolar lavage sample. She was started on combination therapy with ethambutol, azithromycin and levofloxacin. A follow-up chest CT, three weeks after, revealed marked decrease in the endotracheal mass. At four weeks after discharge patient reported no shortness of breath, occasional cough and no hemoptysis.

DISCUSSION: Initiation of HAART induces immune reconstitution that is typically uneventful. We believe our patient developed immune reconstitution syndrome in response to MAC infection that was asymptomatic prior to HAART. Primary prophylaxis for MAC at the time HAART was initiated did not prevent the pulmonary manifestations. Her favorable outcome likely reflects further immune reconstitution as well as antibiotics.

CONCLUSIONS: Tumor-like endobronchial masses due to MAC can develop as part of immune reconstitution even with macrolide prophylaxis. Onset of respiratory symptoms and pulmonary infiltrates within 2 to 4 weeks of initiation of antiretroviral therapy should prompt evaluation for mycobacterial disease.

Reference #1: Peter Phillips et al. Nontuberculous Mycobacterial Immune Reconstitution Syndrome in HIV-Infected Patients: Spectrum of Disease and Long-Term Follow-Up. Clinical Infectious Diseases 2005; 41:1483-97

Reference #2: Kalayjian R C et al. Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS. Clin Infect Dis 1995; 20: 1186-1194.

DISCLOSURE: The following authors have nothing to disclose: Sebastian Circo, Thomas Dillard, WIlliam Davis

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Mycobacterial infections.
New York State Department of Health | 6/20/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543